ELLIOT SIGAL Insider Trading $ONCE Spark Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ELLIOT SIGAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ELLIOT SIGAL. ELLIOT SIGAL is CSO & President PRI in BRISTOL MYERS SQUIBB CO ($BMY) and EVP, CSO & President PRI in BRISTOL MYERS SQUIBB CO ($BMY) and EVP, CSO & President R&D in BRISTOL MYERS SQUIBB CO ($BMY) and SVP, Global Clin & Pharm Dev in BRISTOL MYERS SQUIBB CO ($BMY) and Director in Mead Johnson Nutrition Co ($MJN) and Director in Spark Therapeutics, Inc. ($ONCE).
ELLIOT SIGAL in Spark Therapeutics, Inc.
Trading Symbol: ONCEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ELLIOT SIGAL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2019
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ELLIOT SIGAL in Spark Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMY, MJN, ONCE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | U | 114.50 | 14,214 | 1,627,503 | 0 | 14.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | U | 114.50 | 14,214 | 1,627,503 | 0 | 14.2 K to 0 (-100.00 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,500 | 0 | 14,214 | 12.7 K to 14.2 K (+11.80 %) |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,500 | 0 | 12,714 | 11.2 K to 12.7 K (+13.38 %) |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,500 | 0 | 12,714 | 11.2 K to 12.7 K (+13.38 %) |
Apr 16 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | S | 72.43 | 29 | 2,100 | 11,214 | 11.2 K to 11.2 K (-0.26 %) |
Apr 16 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | P | 90.75 | 29 | 2,632 | 11,243 | 11.2 K to 11.2 K (+0.26 %) |
Jun 02 2017 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
Jun 02 2017 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 50.93 | 4,000 | 203,720 | 4,000 | |
Jun 03 2016 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 56.22 | 6,000 | 337,320 | 6,000 |
Page: 1